[go: up one dir, main page]

DE69630610D1 - Stimulierung der haarfollikel - Google Patents

Stimulierung der haarfollikel

Info

Publication number
DE69630610D1
DE69630610D1 DE69630610T DE69630610T DE69630610D1 DE 69630610 D1 DE69630610 D1 DE 69630610D1 DE 69630610 T DE69630610 T DE 69630610T DE 69630610 T DE69630610 T DE 69630610T DE 69630610 D1 DE69630610 D1 DE 69630610D1
Authority
DE
Germany
Prior art keywords
stimulating
follicules
hair
hair follicules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69630610T
Other languages
English (en)
Other versions
DE69630610T2 (de
Inventor
Norman Weiner
F Wallach
Kamel Egbaria
Ramachandran Chandrasekharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micro Pak Inc
University of Michigan Ann Arbor
Original Assignee
Micro Pak Inc
University of Michigan Ann Arbor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Pak Inc, University of Michigan Ann Arbor filed Critical Micro Pak Inc
Publication of DE69630610D1 publication Critical patent/DE69630610D1/de
Application granted granted Critical
Publication of DE69630610T2 publication Critical patent/DE69630610T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69630610T 1995-10-06 1996-09-30 Stimulierung der haarfollikel Expired - Fee Related DE69630610T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US539865 1983-10-07
US08/539,865 US5834014A (en) 1995-10-06 1995-10-06 Stimulation of hair follicles
PCT/US1996/015686 WO1997012602A1 (en) 1995-10-06 1996-09-30 Stimulation of hair follicles

Publications (2)

Publication Number Publication Date
DE69630610D1 true DE69630610D1 (de) 2003-12-11
DE69630610T2 DE69630610T2 (de) 2004-09-16

Family

ID=24152985

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630610T Expired - Fee Related DE69630610T2 (de) 1995-10-06 1996-09-30 Stimulierung der haarfollikel

Country Status (6)

Country Link
US (1) US5834014A (de)
EP (1) EP0863747B1 (de)
AU (1) AU7382096A (de)
CA (1) CA2233961C (de)
DE (1) DE69630610T2 (de)
WO (1) WO1997012602A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
WO2002064088A2 (en) * 2001-02-14 2002-08-22 Niazi Sarfaraz K Pharmaceutical composition for the treatment of alopecia
US20030129180A1 (en) * 2001-08-01 2003-07-10 The Proctor & Gamble Company Products and methods for treating microbial infections
US20080234225A1 (en) * 2004-03-15 2008-09-25 John Lezdey Method of treatment
WO2006020230A2 (en) * 2004-07-21 2006-02-23 Medtronic, Inc. METHODS FOR REDUCING OR PREVENTING LOCALIZED FIBROSIS USING SiRNA
WO2006020231A2 (en) * 2004-07-21 2006-02-23 Medtronic, Inc. Medical devices and methods for reducing localized fibrosis
CN101180037A (zh) * 2005-03-21 2008-05-14 莱夫克尔创新私人有限公司 一种新的层间和层内多层囊泡制品
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
EP2124885A2 (de) * 2006-10-27 2009-12-02 Giuseppe Trigiante Zusammensetzungen und verfahren zur vorbeugung von haarausfall
FR2914189A1 (fr) 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
US20080254055A1 (en) * 2007-04-11 2008-10-16 John Erich Oblong Compositions for Regulation of Hair Growth
FR2918885B1 (fr) 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2920309B1 (fr) 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
PT2344198T (pt) * 2008-09-27 2020-12-04 Jina Pharmaceuticals Inc Preparações farmacêuticas à base de lípidos para aplicação tópica
EP2459187B1 (de) 2009-07-29 2021-01-06 Olsen, Elise Zusammensetzungen und verfahren zur hemmung von haarwachstum
US9271917B2 (en) 2010-01-29 2016-03-01 Nyangenya Maniga Method and apparatus for delivery of a measured dosage of a non-aerosol, non-spray foam composition of minoxidil
US20110189114A1 (en) * 2010-01-29 2011-08-04 Nyangenya Maniga minoxidil composition and non-aerosol, non-spray foam method of delivery therefor
US9588118B2 (en) 2010-09-24 2017-03-07 Follea International Devices for performing colorimetric assay with plucked human hair
US10633688B2 (en) 2010-09-24 2020-04-28 Follea International Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia
US8691518B2 (en) 2010-09-24 2014-04-08 Global Life Science Partners Limited Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia
US10376562B2 (en) 2013-03-15 2019-08-13 The Jackson Laboratory Methods for promoting wound healing and hair growth comprising GDNF administration
US8642097B1 (en) 2013-03-19 2014-02-04 Nyangenya Maniga Natural product energy drink and method of use thereof
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
WO2016055961A1 (en) * 2014-10-09 2016-04-14 Farmalabor S.R.L. Minoxidil-based pharmaceutical formulation for the topical use and kit thereof
US10561593B2 (en) 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
WO2019113210A1 (en) 2017-12-05 2019-06-13 Anthos Partners, Lp Phosphonium-based ionic drug conjugates
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
EP3801734A4 (de) 2018-05-30 2022-03-16 Follica, Inc. Verfahren zur förderung von haarwachstum
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
US12539302B2 (en) 2019-08-07 2026-02-03 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
PL3886799T3 (pl) 2019-08-07 2024-03-18 Aneira Pharma, Inc. Kompozycje do leczenia utraty włosów
CN114366707A (zh) * 2022-02-23 2022-04-19 山东大学 具有养发育发功效的中草药活性物@囊泡复合物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5147723A (en) * 1987-07-28 1992-09-15 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5030442A (en) * 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
US5032457A (en) * 1988-03-03 1991-07-16 Micro Vesicular Systems, Inc. Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles

Also Published As

Publication number Publication date
CA2233961C (en) 2011-02-15
AU7382096A (en) 1997-04-28
WO1997012602A1 (en) 1997-04-10
EP0863747A4 (de) 1999-03-17
EP0863747A1 (de) 1998-09-16
DE69630610T2 (de) 2004-09-16
EP0863747B1 (de) 2003-11-05
CA2233961A1 (en) 1997-04-10
US5834014A (en) 1998-11-10

Similar Documents

Publication Publication Date Title
DE69630610D1 (de) Stimulierung der haarfollikel
DE59803780D1 (de) Haarformgerät
DE69820860D1 (de) Herzschrittmacher
DE69725330D1 (de) Herzschrittmacher
DE69836690D1 (de) Herzschrittmacher
FR2736272B1 (fr) Stimulateur lombo-abdominal
DE59607418D1 (de) Haarbehandlungsmittel
DE69511580D1 (de) Lockenwickler
DE69517403D1 (de) Lockenwickel
KR970011932U (ko)
KR960030225U (ko) 립스틱 케이스
DE69522489D1 (de) Haarkräftigungsmittel
MD281F1 (ro) Masajor magnetodinamic
KR960030224U (ko) 립스틱 케이스
KR960030226U (ko) 립스틱 케이스
KR960030227U (ko) 립스틱 케이스
KR970027099U (ko) 안마기
KR970028220U (ko) 판박이식 매니큐어
KR950024525U (ko) 침관
BR9501953A (pt) Estimulador facial
KR960009992U (ko) 사우나 겸용 욕조
SE9504332D0 (sv) Pacemaker
KR960019803U (ko) 화장용구
KR960026562U (ko) 립스틱
KR960033355U (ko) 분첩케이스 망

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee